Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Cutera Inc Stock Research

CUTR

4.93USD-0.40(-7.50%)Delayedas of 03 Oct 2023, 01:16 pm
Watchlist

Market Summary

USD4.93-0.40
Delayedas of 03 Oct 2023, 01:16 pm
-7.50%

CUTR Alerts

  • 2 major insider buys recently.
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

CUTR Stock Price

CUTR RSI Chart

CUTR Valuation

Market Cap

106.1M

Price/Earnings (Trailing)

-1.39

Price/Sales (Trailing)

0.43

EV/EBITDA

1.15

Price/Free Cashflow

-0.73

CUTR Price/Sales (Trailing)

CUTR Profitability

EBT Margin

-36.31%

Return on Assets

-18.45%

Free Cashflow Yield

-137.27%

CUTR Fundamentals

CUTR Revenue

Revenue (TTM)

246.4M

Revenue Y/Y

-4.68%

Revenue Q/Q

11.32%

CUTR Earnings

Earnings (TTM)

-76.6M

Earnings Y/Y

33.07%

Earnings Q/Q

-26.5%

Price Action

52 Week Range

4.9352.89
(Low)(High)

Last 7 days

-17.5%

Last 30 days

-53.9%

Last 90 days

-65.2%

Trailing 12 Months

-88.3%

CUTR Financial Health

Current Ratio

3.85

CUTR Investor Care

Shares Dilution (1Y)

6.43%

Diluted EPS (TTM)

-3.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CUTR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-01
Karavitis Michael
sold (taxes)
-1,064
11.57
-92.00
evp, chief technology officer
2023-09-01
Drummond Stuart
sold (taxes)
-127
11.57
-11.00
interim cfo
2023-08-29
Drummond Stuart
bought
49,000
9.8
5,000
interim cfo
2023-08-29
Harris Taylor C.
bought
297,300
9.91
30,000
chief executive officer
2023-08-28
Jones Jeffrey S
acquired
-
-
12,306
chief operating officer
2023-08-18
Harris Taylor C.
acquired
-
-
249,336
-
2023-08-01
Karavitis Michael
sold (taxes)
-1,786
19.63
-91.00
evp, chief technology officer
2023-08-01
HOPKINS SHEILA
acquired
-
-
6,368
interim ceo
2023-08-01
Drummond Stuart
sold (taxes)
-215
19.63
-11.00
interim cfo
2023-07-03
Karavitis Michael
sold (taxes)
-1,407
15.3
-92.00
evp, chief technology officer

1–10 of 50

Which funds bought or sold CUTR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
53.44
-31,000
1,807,000
-%
2023-09-12
Farther Finance Advisors, LLC
sold off
-100
-4,275
-
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-11.16
-203,136
268,225
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-88.44
-120,000
10,000
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
341
9,812
15,173
-%
2023-08-18
Legato Capital Management LLC
added
36.00
-91,023
615,428
0.08%
2023-08-16
Nuveen Asset Management, LLC
reduced
-26.09
-795,548
715,452
-%
2023-08-15
BENJAMIN F. EDWARDS & COMPANY, INC.
unchanged
-
-2,000
3,000
-%
2023-08-15
State of Tennessee, Treasury Department
unchanged
-
-51,491
91,764
-%
2023-08-15
LAZARD ASSET MANAGEMENT LLC
reduced
-38.15
-1,771,000
1,162,000
-%

1–10 of 37

Latest Funds Activity

Are funds buying CUTR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CUTR
No. of Funds

Schedule 13G FIlings of Cutera

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 31, 2023
pura vida investments, llc
7.82%
1,554,795
SC 13D/A
Jul 25, 2023
pura vida investments, llc
6.35%
1,263,602
SC 13D/A
Jul 07, 2023
blackrock inc.
6.3%
1,255,462
SC 13G/A
Jun 13, 2023
voce capital management llc
4.7%
930,696
SC 13D/A
Jun 12, 2023
pura vida investments, llc
7.47%
1,482,281
SC 13D/A
May 16, 2023
point72 asset management, l.p.
5.5%
1,088,100
SC 13G
May 15, 2023
voce capital management llc
6.1%
1,210,224
SC 13D/A
May 10, 2023
rtw investments, lp
9.3%
1,846,596
SC 13D/A
May 10, 2023
pura vida investments, llc
6.16%
1,218,183
SC 13D/A
Apr 13, 2023
rtw investments, lp
9.3%
1,846,596
SC 13D

Recent SEC filings of Cutera

View All Filings
Date Filed Form Type Document
Sep 05, 2023
4
Insider Trading
Sep 05, 2023
4
Insider Trading
Aug 30, 2023
3
Insider Trading
Aug 30, 2023
4
Insider Trading
Aug 30, 2023
4
Insider Trading
Aug 30, 2023
4
Insider Trading
Aug 24, 2023
8-K
Current Report
Aug 22, 2023
4
Insider Trading
Aug 11, 2023
S-8
Employee Benefits Plan
Aug 09, 2023
10-Q
Quarterly Report

Peers (Alternatives to Cutera)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
103.6B
6.7B
-4.97% 57.37%
72.72
15.55
11.75% -0.66%
103.5B
31.6B
-5.31% -3.69%
28.53
3.28
1.57% -30.40%
42.1B
5.7B
-9.43% -16.28%
30.27
7.43
5.64% -4.53%
22.9B
3.7B
-20.04% 44.73%
73.04
6.14
-6.33% -49.26%
17.0B
4.0B
-8.32% 6.74%
35.13
4.21
-22.73% -67.98%
MID-CAP
9.1B
937.8M
-9.65% 25.86%
313.94
9.75
16.30% 250.21%
4.5B
2.6B
-14.85% -15.97%
20.83
1.75
1.78% -15.77%
3.0B
1.1B
-10.10% 23.89%
34.49
2.67
9.28% 177.49%
2.8B
1.1B
-5.71% 3.72%
-29.18
2.61
6.60% -233.50%
1.7B
151.1M
-23.64% 26.45%
-96.88
11.38
193.70% 62.80%
SMALL-CAP
1.2B
177.1M
-23.71% -16.88%
-19.22
6.6
23.02% 15.37%
945.1M
780.7M
-5.83% -7.35%
-26.25
1.21
4.68% -510.17%
583.4M
162.2M
0.22% -40.97%
-6.94
3.6
9.71% 12.37%
120.1M
349.3M
-16.18% -78.67%
-1.25
0.34
-1.13% -239.54%
21.3M
414.9M
-67.24% -82.21%
-0.26
0.05
-23.37% 16.91%

Cutera News

Best Stocks
Cutera Inc Appoints Brent Hauser as President International to Drive ....
Best Stocks,
27 hours ago
Financial Post
Yahoo Finance
Seeking Alpha

Returns for CUTR

Cumulative Returns on CUTR

-5.0%


10-Year Cumulative Returns

-10.9%


7-Year Cumulative Returns

-29.3%


5-Year Cumulative Returns

-33.7%


3-Year Cumulative Returns

Risks for CUTR

What is the probability of a big loss on CUTR?

98.5%


Probability that Cutera stock will be more than 20% underwater in next one year

79.6%


Probability that Cutera stock will be more than 30% underwater in next one year.

65.4%


Probability that Cutera stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CUTR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cutera was unfortunately bought at previous high price.

Drawdowns

Financials for Cutera

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-1.2%246,372,000249,378,000252,399,000250,675,000245,251,000239,616,000231,270,000215,584,000197,332,000165,112,000147,683,000149,535,000156,520,000177,925,000181,712,000175,386,000169,842,000164,621,000162,720,000164,883,000162,483,000
Gross Profit-5.3%125,978,000132,968,000139,829,000139,261,000138,438,000137,183,000133,105,000122,990,000111,311,00089,146,00075,772,00076,496,00080,983,00095,190,00098,163,00088,159,00083,811,00080,357,00080,382,00088,929,00089,254,000
Operating Expenses6.9%194,045,000181,570,000178,019,000173,944,000163,062,000149,675,000131,275,000117,688,000107,846,00098,680,00098,600,000102,696,000108,381,000111,358,000110,228,000103,785,00098,026,00097,026,00093,774,00092,288,00085,399,000
  S&GA Expenses5.6%117,785,000111,515,000106,947,000102,527,00095,229,00086,638,00076,762,00067,324,00060,420,00053,045,00052,766,00058,433,00063,838,00069,795,00071,110,00066,105,00062,893,00061,436,00058,420,00058,464,00057,133,000
  R&D Expenses-4.3%24,049,00025,124,00025,155,00026,551,00025,964,00023,955,00021,568,00018,793,00016,423,00014,564,00014,322,00014,756,00014,967,00015,249,00015,085,00014,086,00013,687,00014,509,00014,359,00014,376,00014,599,000
EBITDA100.0%--82,718,000-75,044,000-72,689,000-63,281,000-7,022,0007,199,000---9,274,000-21,700,000-25,162,000-26,124,000-14,851,000-10,539,000-14,120,000-12,612,000----
EBITDA Margin100.0%--0.33-0.30-0.29-0.26-0.030.03---0.06-0.15-0.17-0.17-0.08-0.06-0.08-0.07----
Interest Expenses23.1%9,628,0007,819,0005,658,0004,443,0003,472,0003,101,0002,514,0001,737,000969,000191,000--------85,000--
Earnings Before Taxes17.8%-74,393,000-90,537,000-80,702,000-77,132,000-66,753,000-11,423,0003,385,0008,289,0007,624,000-11,172,000-23,407,000-26,806,000-27,768,000-16,495,000-12,264,000-15,849,000-14,341,000-16,970,000-13,516,000-3,301,0004,159,000
EBT Margin100.0%--0.36-0.32-0.31-0.27-0.050.010.040.04-0.07-0.16-0.18-0.18-0.09-0.07------
Net Income17.0%-76,582,000-92,214,000-82,340,000-78,487,000-67,743,000-12,721,0002,062,0008,185,0007,318,000-11,822,000-23,877,000-28,153,000-28,524,000-16,542,000-12,348,000-36,553,000-34,798,000-36,958,000-30,770,00018,403,00025,464,000
Net Income Margin100.0%--0.37-0.33-0.31-0.28-0.050.010.040.04-0.07-0.16-0.19-0.18-0.09-0.07------
Free Cashflow100.0%--107,985,000-89,693,000-62,045,000-42,551,000-30,857,000220,0002,153,0004,621,000-4,865,000-18,213,000-18,666,000-17,359,000-7,386,000-3,208,000------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-7.2%46450052142842426728026826426013312311394.0011411110897.0098.00119116
  Current Assets-11.6%37041845136637323725024223923410696.0097.0077.0095.0092.0088.0078.0087.0087.0085.00
    Cash Equivalents8.3%18116714646.0076.0058.0016516216916547.0029.0034.0015.0026.0023.0028.0019.0026.0022.0018.00
  Inventory-4.4%69.0072.0064.0056.0045.0052.0040.0035.0035.0035.0029.0029.0031.0037.0034.0034.0027.0027.0028.0031.0030.00
  Net PPE----------2.002.002.002.003.003.003.003.002.003.003.003.00
  Goodwill0%1.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.00
Liabilities-1.1%53353953641340022422421321121876.0071.0061.0061.0068.0067.0065.0058.0051.0049.0046.00
  Current Liabilities-5.3%10310910698.0086.0074.0074.0063.0060.0066.0054.0045.0045.0052.0059.0055.0053.0047.0048.0045.0043.00
  Long Term Debt-----------4.007.007.00--------
Shareholder's Equity-77.2%-69.14-39.01-15.1815.0024.0043.0057.0055.0053.0042.0057.0052.0052.0034.0046.0044.0043.0039.0046.0070.0069.00
  Retained Earnings-19.1%-197-165-140-132-120-73.31-58.17-54.24-52.85-60.59-60.23-62.42-60.17-48.77-36.36-34.27-31.64-32.23-24.012.003.00
  Additional Paid-In Capital1.2%12812712514914511611511010610211711411382.0082.0078.0075.0071.0070.0068.0066.00
Shares Outstanding0.6%20.0020.0020.0020.0019.0018.0018.0018.0018.0018.0018.0018.0017.0014.0014.0014.0014.0014.0014.0014.0014.00
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-41.3%-105,240-74,455-66,995-47,305-33,668-29,6221,2353,0405,835-3,715-16,934-17,425-16,249-6,230-2,2172,2332,8922,402308-1,4373,894
  Share Based Compensation-23.2%10,56013,74314,40017,68617,18315,36913,17210,5598,7999,97510,10910,88512,08110,5059,8328,6377,0906,7767,1577,0116,377
Cashflow From Investing307.0%122,990-59,423-194,182-220,022-212,192-75,274-94412,26311,7923,7006,389-7,785-9,9192,1581,067-2,0915,4463,77210,77329,00522,772
Cashflow From Financing-63.8%87,854242,974242,937151,421152,410-1,604117,526117,789117,914150,17331,27631,72532,159-3121,4148718982,074787-20,486-26,913

CUTR Income Statement

2023-06-30
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Net revenue:    
Total net revenue$ 61,218$ 64,224$ 116,211$ 122,238
Cost of revenue:    
Total cost of revenue33,16429,18063,23055,406
Gross profit28,05435,04452,98166,832
Operating expenses:    
Sales and marketing33,27127,00162,78351,945
Research and development5,7846,85912,25213,358
General and administrative18,52811,24831,04424,750
Total operating expenses57,58345,108106,07990,053
Loss from operations(29,529)(10,064)(53,098)(23,221)
Interest and other expense, net:    
Amortization of debt issuance costs(557)(298)(1,109)(517)
Interest on convertible notes(2,958)(1,149)(5,897)(1,927)
Loss on extinguishment of convertible notes  0(34,423)
Interest income2,1793824,658395
Other expense, net(453)(1,910)(616)(2,678)
Total interest and other expense, net(1,789)(37,398)(2,964)(39,150)
Loss before income taxes(31,318)(47,462)(56,062)(62,371)
Income tax expense (benefit)326(186)59847
Net loss$ (31,644)$ (47,276)$ (56,660)$ (62,418)
Net loss per share:    
Basic (USD per share)$ (1.59)$ (2.53)$ (2.86)$ (3.39)
Diluted (USD per share)$ (1.59)$ (2.53)$ (2.86)$ (3.39)
Weighted-average number of shares used in per share calculation:    
Basic (in shares)19,85818,70019,81918,392
Diluted (in shares)19,85818,70019,81918,392
Convertible notes    
Interest and other expense, net:    
Loss on extinguishment of convertible notes$ 0$ (34,423)$ 0$ (34,423)
Total product revenue    
Net revenue:    
Total net revenue55,56858,589105,156110,655
Cost of revenue:    
Total cost of revenue29,47325,89956,70448,811
Service    
Net revenue:    
Total net revenue5,6505,63511,05511,583
Cost of revenue:    
Total cost of revenue$ 3,691$ 3,281$ 6,526$ 6,595

CUTR Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 180,654$ 145,924
Marketable investments41,949171,390
Accounts receivable, net of allowance for credit losses of $5,011 and $2,497, respectively53,07945,562
Inventories, net68,66863,628
Other current assets and prepaid expenses24,90024,036
Restricted cash700700
Total current assets369,950451,240
Property and equipment, net65,51140,368
Deferred tax assets547590
Goodwill1,3391,339
Operating lease right-of-use assets11,37012,831
Other long-term assets15,11314,620
Total assets463,830520,988
Current liabilities:  
Accounts payable34,24033,736
Accrued liabilities53,76457,452
Operating lease liabilities2,6022,810
Deferred revenue12,45711,841
Total current liabilities103,063105,839
Deferred revenue, net of current portion1,6901,657
Operating lease liabilities, net of current portion10,06911,352
Convertible notes, net of unamortized debt issuance costs of $11,557 and $12,666, respectively417,568416,459
Other long-term liabilities575862
Total liabilities532,965536,169
Commitments and Contingencies (Note 13)
Stockholders’ deficit:  
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 19,901,600 and 19,668,603 shares at June 30, 2023 and December 31, 2022, respectively2020
Additional paid-in capital128,014125,406
Accumulated other comprehensive income (loss)4(94)
Accumulated deficit(197,173)(140,513)
Total stockholders’ deficit(69,135)(15,181)
Total liabilities and stockholders’ deficit$ 463,830$ 520,988
David H. Mowry
460
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.